Decision Aid Summary
|Title||Stage IB, II, III Non-Small Cell Lung Cancer Cisplatin plus Vinorelbine Chemotherapy after Surgery|
|Audience||Clinicians, primarily Medical Oncologists; also, other oncology health professionals; patients, families, other members of patient's social support network. The first time a patient/caregiver uses the DA should be with the patient's cancer doctor.|
|Options included||Taking cisplatin-vinorelbine chemotherapy after surgery.
|Year of last update or review||2017|
|How to obtain||Click here to view the decision aid on the developer website|
|Developer||American Society of Clinical Oncology (ASCO)|
|Where was it developed?||www.asco.org/guidelines, firstname.lastname@example.org
American Society of Clinical Oncology
|Health condition||Lung Cancer|
|Type of decision aid||Treatment|
|Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:|
|6 out of 7 criteria to be defined as a patient decision aid|
|4 out of 9 criteria to lower the risk of making a biased decision|
|Not applicable: other criteria for decision aids about screening or testing|
Last modified: 2019-06-26.